Athyrium Healthcare Strategic Income & Growth IDF LLC — Form D/A
Athyrium Healthcare Strategic Income & Growth IDF LLC of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2020-01-06. $25.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-01-06
- Form: D/A
- Accession: 0001697878-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $25.2M
- Investors: 8
- Date of first sale: 2017-02-01
- Security types: fund interests
- SEC file number: 021-280862
Issuer
- Name: Athyrium Healthcare Strategic Income & Growth IDF LLC
- CIK: 0001697878
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: C/O ATHYRIUM CAPITAL MANAGEMENT, LP, NEW YORK, NY, 10017
- Phone: 212-402-6925
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| ELIN C STRONG | Executive Officer | NEW YORK, NY |
| ANDREW C HYMAN | Executive Officer | NEW YORK, NY |
| RASHIDA J ADAMS | Executive Officer | NEW YORK, NY |
| COURTNEY C PAUL | Executive Officer | NEW YORK, NY |
| PAUL A WAKEFIELD | Executive Officer | NEW YORK, NY |
| JEREMY D LACK | Executive Officer | NEW YORK, NY |
| Jeffrey A Ferrell | Executive Officer | San Diego, CA |
Other filings by this issuer (4)
More